Metraipolis › archive › dc_bf285dc2d28e

JNK pathway suppression mediates insensitivity to combination endocrine therapy and CDK4/6 inhibition in ER+ breast cancer — Europe PMC PMID:40826108

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/40826108
DOI: 10.1186/s13046-[numero omesso]-9
License (as archived): solo-consultazione
Archived: 2026-11-10T12:39:12.448Z
SHA-256 of the archived text: 8d9ae321cabbeedcae4ccda14c3bf3caecfdc068c6a5c87cbd3cb83b4720f2a2
Stable URL of this page: https://metraipolis.com/documento/dc_bf285dc2d28e

How to cite

JNK pathway suppression mediates insensitivity to combination endocrine therapy and CDK4/6 inhibition in ER+ breast cancer — Europe PMC PMID:40826108 — Europe PMC (en), https://europepmc.org/article/MED/40826108 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_bf285dc2d28e (Metraipolis archive dc_bf285dc2d28e, sha256 8d9ae321cabbeedcae4ccda14c3bf3caecfdc068c6a5c87cbd3cb83b4720f2a2)

BibTeX

@misc{dcbf285dc2d28e,
  title = {JNK pathway suppression mediates insensitivity to combination endocrine therapy and CDK4/6 inhibition in ER+ breast cancer — Europe PMC PMID:40826108},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/40826108},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_bf285dc2d28e; sha256 8d9ae321cabbeedcae4ccda14c3bf3caecfdc068c6a5c87cbd3cb83b4720f2a2},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40826108. Agents can read the archived copy with the MCP tool read_document.